<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Energetic–Geometry Selective Vulnerability (EGSV) of Neurons in Alzheimer’s Disease - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-31</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-31</p>
                <p><strong>Name:</strong> Energetic–Geometry Selective Vulnerability (EGSV) of Neurons in Alzheimer’s Disease</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of which brain cell types are most susceptible and most resilient in Alzheimer's disease and why, based on the following results.</p>
                <p><strong>Description:</strong> Neuronal susceptibility in Alzheimer’s disease follows an energetic–geometry rule: long-range, high-surface-area, high-synapse-load projection neurons embedded in metabolically intensive networks (e.g., medial temporal lobe and posterior cingulate cortex) are earliest and most vulnerable because they enter a coordinated down-regulation of nuclear-encoded mitochondrial electron-transport-chain (ETC) and import (TIMM/TOMM) genes while undergoing early synaptic proteome loss; conversely, neurons in primary sensory/motor cortices and specific projection subclasses (e.g., Betz cells) are relatively resilient. Laminar/subfield patterns (entorhinal layer II/IV and CA1 vulnerable; CA3/dentate more resilient) reflect this principle; network hyperexcitability further amplifies energetic stress and accelerates degeneration in susceptible classes.</p>
                <p><strong>Knowledge Cutoff Year:</strong> 2029</p>
                <p><strong>Knowledge Cutoff Month:</strong> 12</p>
                <p><strong>Base Model:</strong> openai/gpt-5</p>
            </div>
        </div>
        </div>

        <div class="section">
            <h2>Theory (Statement/Laws)</h2>

            <h3>Theory Statements/Laws</h3>
            <hr/>
            <h3>Statement 0: Mitochondrial transcriptional downshift threshold predicts regional neuronal vulnerability</h3>
            <p><strong>Statement:</strong> In cortical and hippocampal regions where ≥50% of nuclear-encoded ETC/translocase genes are underexpressed in morphologically non–tangle-bearing pyramidal neurons, those neuronal populations are selectively vulnerable and show early synaptic protein loss and/or cell loss in AD; where ≤20% of these genes are underexpressed, neurons are relatively resilient.</p>
            <p><strong>Domain/Scope:</strong> Human postmortem late-onset AD; laser-capture–profiled layer III pyramidal neurons from posterior cingulate, middle temporal gyrus, visual cortex, superior frontal gyrus; hippocampal CA1 neurons; bulk cortical proteomes from entorhinal/parahippocampal cortex and neocortex across control→AsymAD→AD. Applies to regional/laminar comparisons (population-level), not to single-synapse physiology.</p>
            <h4>Special Cases</h4>
            <ol>
                <li>Entorhinal cortex (EC) layer II stellate neurons show ~23% ETC downshift yet are among the earliest to die, indicating that additional drivers (e.g., local tau vulnerability, circuit topology) can override the metabolic threshold.</li>
                <li>Late-stage disease may involve visual cortex despite early sparing; thresholds describe early-to-mid-stage selectivity patterns.</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Posterior cingulate cortex (PCC) layer III neurons: 70% of nuclear-encoded ETC/translocase genes underexpressed; protein decreases in ETC complexes I–V confirmed. <a href="../results/extraction-result-204.html#e204.0" class="evidence-link">[e204.0]</a> <a href="../results/extraction-result-198.html#e198.8" class="evidence-link">[e198.8]</a> </li>
    <li>Middle temporal gyrus (MTG) layer III neurons: 65% of nuclear-encoded ETC/translocase genes underexpressed. <a href="../results/extraction-result-204.html#e204.1" class="evidence-link">[e204.1]</a> </li>
    <li>Hippocampal CA1 pyramidal neurons (non–tangle-bearing): ~61% nuclear-encoded ETC/translocase genes underexpressed. <a href="../results/extraction-result-204.html#e204.2" class="evidence-link">[e204.2]</a> <a href="../results/extraction-result-198.html#e198.0" class="evidence-link">[e198.0]</a> <a href="../results/extraction-result-190.html#e190.1" class="evidence-link">[e190.1]</a> <a href="../results/extraction-result-191.html#e191.0" class="evidence-link">[e191.0]</a> </li>
    <li>Primary visual cortex (V1) layer III neurons: 16% underexpressed (relative resilience); superior frontal gyrus: ~5–10% underexpressed. <a href="../results/extraction-result-204.html#e204.4" class="evidence-link">[e204.4]</a> <a href="../results/extraction-result-204.html#e204.5" class="evidence-link">[e204.5]</a> </li>
    <li>Bulk proteomics across regions shows early and progressive synaptic proteome loss, especially in MTL; neuronal modules decline in AsymAD. <a href="../results/extraction-result-202.html#e202.0" class="evidence-link">[e202.0]</a> <a href="../results/extraction-result-201.html#e201.0" class="evidence-link">[e201.0]</a> <a href="../results/extraction-result-203.html#e203.4" class="evidence-link">[e203.4]</a> </li>
    <li>EC layer II stellate neurons show ~23% ETC/translocase underexpression despite early vulnerability (exception supporting special case). <a href="../results/extraction-result-204.html#e204.3" class="evidence-link">[e204.3]</a> <a href="../results/extraction-result-194.html#e194.0" class="evidence-link">[e194.0]</a> <a href="../results/extraction-result-190.html#e190.0" class="evidence-link">[e190.0]</a> <a href="../results/extraction-result-191.html#e191.1" class="evidence-link">[e191.1]</a> <a href="../results/extraction-result-198.html#e198.2" class="evidence-link">[e198.2]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> closely-related-to-existing</p>
        <p><strong>Explanation:</strong> Integrates multi-regional LCM neuronomics and bulk proteomics into a predictive criterion for selective vulnerability; extends but remains close to existing observations.</p>            <p><strong>What Already Exists:</strong> Regional hypometabolism in PCC/MTL, neuron LCM evidence of ETC underexpression, and synapse loss as an early correlate of cognition are established.</p>            <p><strong>What is Novel:</strong> A simple, testable threshold rule (≥50% ETC/translocase downshift → early vulnerability; ≤20% → resilience) unifying LCM neuron data with regional proteomic synapse-loss trajectories.</p>
        <p><strong>References:</strong> <ul>
    <li>Liang (2008) Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons [LCM mitochondrial downshift]</li>
    <li>Seyfried (2017) A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease [Synaptic module decline precedes symptoms]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
            <h3>Statement 1: Geometry–load law for projection neurons</h3>
            <p><strong>Statement:</strong> Neuronal classes with long axons, extensive dendritic arbors, high neurofilament content, and high synaptic input density (e.g., EC layer II/IV, hippocampal CA1, association-layer III–VI pyramids) are more susceptible than local-circuit or primary sensory/motor neurons; CA3 and dentate granule cells are relatively resistant.</p>
            <p><strong>Domain/Scope:</strong> Human neuropathology across hippocampus/entorhinal cortex and association neocortex; qualitative law of relative susceptibility among principal cells during AD progression (preclinical to symptomatic).</p>
            <h4>Special Cases</h4>
            <ol>
                <li>Betz cells (large corticospinal neurons) are large but relatively spared, indicating projection length alone is insufficient without network/topologic and proteostatic context.</li>
                <li>Basal forebrain cholinergic neurons are vulnerable via additional mechanisms (loss of neurotrophin receptors and synaptic genes).</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>EC layer II and IV show early, large neuron loss correlated with NFTs and neuritic plaques; laminar specificity. <a href="../results/extraction-result-194.html#e194.0" class="evidence-link">[e194.0]</a> <a href="../results/extraction-result-194.html#e194.1" class="evidence-link">[e194.1]</a> <a href="../results/extraction-result-191.html#e191.1" class="evidence-link">[e191.1]</a> </li>
    <li>CA1 vulnerable vs CA3 relatively resistant; dentate granule neurons relatively resistant. <a href="../results/extraction-result-198.html#e198.0" class="evidence-link">[e198.0]</a> <a href="../results/extraction-result-190.html#e190.1" class="evidence-link">[e190.1]</a> <a href="../results/extraction-result-198.html#e198.1" class="evidence-link">[e198.1]</a> <a href="../results/extraction-result-198.html#e198.7" class="evidence-link">[e198.7]</a> </li>
    <li>Neocortical pyramidal neurons in layers III–VI are severely affected; association areas undergo atrophy. <a href="../results/extraction-result-197.html#e197.4" class="evidence-link">[e197.4]</a> <a href="../results/extraction-result-191.html#e191.6" class="evidence-link">[e191.6]</a> </li>
    <li>Primary sensory/motor cortices are largely spared; corticospinal-projecting Betz cells not involved in AD pathology. <a href="../results/extraction-result-198.html#e198.6" class="evidence-link">[e198.6]</a> <a href="../results/extraction-result-197.html#e197.8" class="evidence-link">[e197.8]</a> </li>
    <li>Large association pyramidal neurons with high neurofilament content highlighted as vulnerable. <a href="../results/extraction-result-198.html#e198.9" class="evidence-link">[e198.9]</a> </li>
    <li>Basal forebrain cholinergic neuron vulnerability (loss, receptor downregulation) complements geometry–load susceptibility in cortical targets. <a href="../results/extraction-result-190.html#e190.3" class="evidence-link">[e190.3]</a> <a href="../results/extraction-result-191.html#e191.2" class="evidence-link">[e191.2]</a> <a href="../results/extraction-result-198.html#e198.4" class="evidence-link">[e198.4]</a> <a href="../results/extraction-result-197.html#e197.6" class="evidence-link">[e197.6]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
        <p><strong>Explanation:</strong> Synthesizes morphology and energetics into a unifying descriptor; extends existing concepts.</p>            <p><strong>What Already Exists:</strong> Selective vulnerability of EC/CA1 and sparing of primary sensory/motor cortex are classical observations.</p>            <p><strong>What is Novel:</strong> Formulating a morphology-and-load constraint that explicitly integrates dendritic/axonal geometry and neurofilament content with metabolic stress to explain laminar/subfield patterns.</p>
        <p><strong>References:</strong> <ul>
    <li>Morrison (1987) Selective pyramidal neuron vulnerability [Morphology-linked susceptibility]</li>
    <li>Braak (1991) Staging of neurofibrillary changes [Spatial progression consistent with geometry–load model]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
            <h3>Statement 2: Early synaptic proteome depletion marks and mediates vulnerability</h3>
            <p><strong>Statement:</strong> Across vulnerable regions, presynaptic and postsynaptic proteins decline early (AsymAD) and track cognitive decline; this synaptic depletion couples to energetic downshift and predicts subsequent neuronal loss.</p>
            <p><strong>Domain/Scope:</strong> Human cortical medial temporal and neocortical regions assayed by bulk proteomics across control→AsymAD→AD; cognition associations where available.</p>
            <h4>Special Cases</h4>
            <ol>
                <li>APP-derived Aβ peptides increase even when holo-APP protein is stable or slightly reduced, reflecting cleavage dynamics rather than synaptic abundance per se.</li>
                <li>Neocortex shows early synaptic dysfunction prior to insoluble tau deposition, indicating synaptic vulnerability can precede overt neurofibrillary pathology in some regions.</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Synaptic protein modules (B-M1/B-M4) decline already in AsymAD and correlate with CERAD/Braak; neuronal modules negatively associated with pathology. <a href="../results/extraction-result-201.html#e201.0" class="evidence-link">[e201.0]</a> <a href="../results/extraction-result-203.html#e203.4" class="evidence-link">[e203.4]</a> </li>
    <li>Proteomics shows >70% synaptic proteins down in MTL and >60% in neocortex during progression; synapse loss is an early and strong correlate of cognitive decline. <a href="../results/extraction-result-202.html#e202.0" class="evidence-link">[e202.0]</a> <a href="../results/extraction-result-196.html#e196.4" class="evidence-link">[e196.4]</a> <a href="../results/extraction-result-196.html#e196.0" class="evidence-link">[e196.0]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> closely-related-to-existing</p>
        <p><strong>Explanation:</strong> Gives a causal ordering hypothesis unified across regions; extends beyond correlation.</p>            <p><strong>What Already Exists:</strong> Synapse loss correlates best with cognition; early synaptic alterations in proteomes are reported.</p>            <p><strong>What is Novel:</strong> An explicit temporal coupling is proposed: preclinical synaptic proteome decline links to, and predicts, mitochondrial downshift and later neuronal loss.</p>
        <p><strong>References:</strong> <ul>
    <li>Terry (1991) Synapse loss and cognition [Classical correlation]</li>
    <li>Seyfried (2017) Proteomic modules in AsymAD [Preclinical synaptic decline]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
            <h3>Statement 3: Regional baseline proteomic program predisposes vulnerability</h3>
            <p><strong>Statement:</strong> Regions with higher baseline expression of mitochondrial, ribosomal/translation, and proteasome proteins (e.g., MTL) in healthy brain show earlier and larger down-regulation of these programs and earlier tau pathology in AD, predisposing their principal neurons to early failure.</p>
            <p><strong>Domain/Scope:</strong> Human regional proteomes from control MTL vs neocortex and progression in AD (EC, PHC, FC, TC).</p>
            <h4>Special Cases</h4>
            <ol>
                <li>APOE protein is higher in MTL controls but isoform distribution and cohort size limit isoform-specific inference in that dataset.</li>
                <li>Not all baseline-enriched pathways are uniformly down-regulated across all MTL subregions simultaneously.</li>
            </ol>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Healthy MTL shows higher mitochondrial, ribosomal, and proteasome proteins and APOE; these programs are preferentially down-regulated in MTL during AD progression. <a href="../results/extraction-result-202.html#e202.2" class="evidence-link">[e202.2]</a> </li>
</ol>            <h4>Self-Evaluation of Law Novelty (produced by the generation model)</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
        <p><strong>Explanation:</strong> Adds a mechanistic precondition to vulnerability beyond pathology exposure.</p>            <p><strong>What Already Exists:</strong> Regional proteomic differences and early MTL involvement are known.</p>            <p><strong>What is Novel:</strong> Explicitly linking baseline proteomic load to subsequent selective vulnerability as a predisposing factor.</p>
        <p><strong>References:</strong> <ul>
    <li>Xu et al. (2019) Proteomic signatures of brain regions affected by tau pathology [Regional baseline differences linked to vulnerability]</li>
</ul>
            <h4>External Evaluations of this Law</h4>
            <p><strong>Predictive Accuracy Evaluation:</strong> <span class="empty-note">Not available.</span></p>
            <p><strong>Novelty Evaluation:</strong> <span class="empty-note">Not available (available only for a randomly selected subset of 100 laws, due to cost).</span></p>
            <hr/>
        </div>
        <div class="section">
            <h2>Theory (Additional Details)</h2>
                        <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Across subjects with matched Braak stage, the proportion of underexpressed nuclear ETC/translocase genes in LCM neurons will correlate with the magnitude of regional synaptic proteome loss (by LC-MS) and with stereological neuron loss when available (e.g., EC II/IV).</li>
                <li>Primary visual cortex and superior frontal gyrus neurons in Braak III–IV will still show ≤20% ETC/translocase downshift compared to PCC/MTG ≥50%.</li>
                <li>Individuals with lower neuronal synaptic module eigenproteins in association cortex will exhibit greater measures of cortical hyperexcitability (EEG/MEG) and faster subsequent cognitive decline.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Pharmacologic upregulation of neuronal mitochondrial biogenesis/import (e.g., PGC-1α agonism) in ex vivo vulnerable human cortical slices will attenuate activity-induced spine loss and stabilize synaptic proteins.</li>
                <li>Chronic suppression of cortical hyperexcitability (e.g., low-dose levetiracetam) in prodromal AD will slow the progression of neuronal ETC/translocase downshift in association cortex neurons longitudinally.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>Finding that primary visual cortex LCM neurons in Braak III–IV commonly exhibit ≥50% ETC/translocase underexpression comparable to PCC would challenge the threshold rule.</li>
                <li>Observing preserved synaptic proteomes in MTL regions despite high neuronal ETC/translocase downshift would argue against the proposed cascade ordering.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>EC layer II stellate neurons show only ~23% ETC/translocase downshift despite early and profound cell loss. <a href="../results/extraction-result-204.html#e204.3" class="evidence-link">[e204.3]</a> <a href="../results/extraction-result-194.html#e194.0" class="evidence-link">[e194.0]</a> </li>
</ol>        </div>        <div style="height: 30px;"></div>
    </div>
</body>
</html>